These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20035021)

  • 1. Safety of triazole antifungal drugs in patients with cancer.
    Cronin S; Chandrasekar PH
    J Antimicrob Chemother; 2010 Mar; 65(3):410-6. PubMed ID: 20035021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and clinical use of voriconazole.
    Thompson GR; Lewis JS
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):83-94. PubMed ID: 19947892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of systemic fungal infections: alternatives to itraconazole.
    Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
    Cecil JA; Wenzel RP
    Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450.
    Gubbins PO
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1411-29. PubMed ID: 21995615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring for triazoles.
    Hope WW; Billaud EM; Lestner J; Denning DW
    Curr Opin Infect Dis; 2008 Dec; 21(6):580-6. PubMed ID: 18978525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of new antifungal agents.
    Kauffman CA
    Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization].
    Scodavolpe S; Quaranta S; Lacarelle B; Solas C
    Ann Biol Clin (Paris); 2014; 72(4):391-404. PubMed ID: 25119797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voriconazole: a new triazole antifungal agent.
    Johnson LB; Kauffman CA
    Clin Infect Dis; 2003 Mar; 36(5):630-7. PubMed ID: 12594645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole -- better chances for patients with invasive mycoses.
    Ghannoum MA; Kuhn DM
    Eur J Med Res; 2002 May; 7(5):242-56. PubMed ID: 12069915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Voriconazole: a new weapon against invasive fungal infections].
    Aoun M
    Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole in the treatment of invasive fungal infections.
    Keady S; Thacker M
    Intensive Crit Care Nurs; 2005 Dec; 21(6):370-3. PubMed ID: 15985371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Level of evidence for therapeutic drug monitoring of posaconazole].
    Lefeuvre S; Jelassi ML; Benlmouden A; Berge M; Le Guellec C; Billaud EM;
    Therapie; 2011; 66(2):115-22. PubMed ID: 21635858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posaconazole: an oral triazole with an extended spectrum of activity.
    Rachwalski EJ; Wieczorkiewicz JT; Scheetz MH
    Ann Pharmacother; 2008 Oct; 42(10):1429-38. PubMed ID: 18713852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posaconazole: clinical pharmacology and potential for management of fungal infections.
    Groll AH; Walsh TJ
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):467-87. PubMed ID: 16107193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.
    Smith WJ; Drew RH; Perfect JR
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):165-81. PubMed ID: 19254165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triazole antifungals: a review.
    Peyton LR; Gallagher S; Hashemzadeh M
    Drugs Today (Barc); 2015 Dec; 51(12):705-18. PubMed ID: 26798851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
    Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH
    Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.